1n5c: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
[[Image:1n5c.gif|left|200px]]
{{Seed}}
[[Image:1n5c.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1n5c|  PDB=1n5c  |  SCENE=  }}  
{{STRUCTURE_1n5c|  PDB=1n5c  |  SCENE=  }}  


'''Crystal Structure Analysis of the B-DNA Dodecamer CGCGAATT(ethenoC)GCG'''
===Crystal Structure Analysis of the B-DNA Dodecamer CGCGAATT(ethenoC)GCG===




==Overview==
<!--
Exocyclic DNA adducts are formed from metabolites of chemical carcinogens and have also been detected as endogenous lesions in human DNA. The exocyclic adduct 3,N(4)-etheno-2'-deoxycytidine (epsilon dC), positioned opposite deoxyguanosine in the B-form duplex of the dodecanucleotide d(CGCGAATTepsilonCGCG), has been crystallographically characterized at 1.8A resolution. This self-complementary oligomer crystallizes in space group P3(2)12, containing a single strand in the asymmetric unit. The crystal structure was solved by isomorphous replacement with the corresponding unmodified dodecamer structure. Exposure of both structures to identical crystal packing forces allows a detailed investigation of the influence of the exocyclic base adduct on the overall helical structure and local geometry. Structural changes are limited to the epsilon C:G and adjacent T:A and G:C base-pairs. The standard Watson-Crick base-pairing scheme, retained in the T:A and G:C base-pairs, is blocked by the etheno bridge in the epsilon C:G pair. In its place, a hydrogen bond involving O2 of epsilon C and N1 of G is present. Comparison with an epsilon dC-containing NMR structure confirms the general conformation reported for epsilon C:G, including the hydrogen bonding features. Superposition with the crystal structure of a DNA duplex containing a T:G wobble pair shows similar structural changes imposed by both mismatches. Evaluation of the hydration shell of the duplex with bond valence calculations reveals two sodium ions in the crystal.
The line below this paragraph, {{ABSTRACT_PUBMED_12787670}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 12787670 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_12787670}}


==About this Structure==
==About this Structure==
Line 26: Line 30:
[[Category: 3,n4-etheno-2'-cytidine modification opposite g]]
[[Category: 3,n4-etheno-2'-cytidine modification opposite g]]
[[Category: B form double helix]]
[[Category: B form double helix]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sat May  3 02:06:55 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun Jul 13 15:17:08 2008''

Revision as of 15:17, 13 July 2008

File:1n5c.png

Template:STRUCTURE 1n5c

Crystal Structure Analysis of the B-DNA Dodecamer CGCGAATT(ethenoC)GCGCrystal Structure Analysis of the B-DNA Dodecamer CGCGAATT(ethenoC)GCG

Template:ABSTRACT PUBMED 12787670

About this StructureAbout this Structure

Full crystallographic information is available from OCA.

ReferenceReference

Crystallographic characterization of an exocyclic DNA adduct: 3,N4-etheno-2'-deoxycytidine in the dodecamer 5'-CGCGAATTepsilonCGCG-3'., Freisinger E, Fernandes A, Grollman AP, Kisker C, J Mol Biol. 2003 Jun 13;329(4):685-97. PMID:12787670

Page seeded by OCA on Sun Jul 13 15:17:08 2008

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA